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identifiable muscle using the clonal populations. When reviewing the previously successful reports of 
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enhance the myogenic conversion rate. This, along with as yet unidentified stromal interplay, may 
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As a continuance of our Institution’s work investigating the biological potentials of oral 
mucosa derived progenitor cells we present an in vitro laboratory study that examines the 
ability of such cell types to undergo myogenic conversion. This work was conducted utilising 
previously derived progenitor cell populations and animal muscle cell lines subjected to two- 
and three-dimensional constructs. Previous work through our group had identified the oral 
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Abstract 
Progenitor cells derived from the oral mucosa lamina propria (OMLP-PCs) demonstrate an 
ability to differentiate into tissue lineages removed from their anatomical origin. This 
clonally derived population of neural-crest cells have demonstrated potential to differentiate 
along mesenchymal and neuronal cell lineages.  
Objective: Significant efforts are being made to generate functioning muscle constructs for 
use in research and clinical tissue engineering. In this study we aimed to determine the 
myogenic properties of clonal populations of expanded OMLP-PCs. 
Design: PCs were subject to several in vitro culture conditions in an attempt to drive 
myogenic conversion. Methodologies include use of demethylation gene-modifying reagents, 
mechanical conditioning of tissue culture substrates, tuneable polyacrylamide gels and a 3-
dimensional construct as well as published myogenic media compositions. PCR and 
immunostaining for the muscle cell markers Desmin and MyoD1 were used to assess muscle 
differentiation.  
Results: The clones tested did not intrinsically express myogenic lineage markers. Despite 
use of two and 3-dimensional pre-published in vitro culture protocols OMLP clones could not 
be differentiated down a myogenic lineage. 
Conclusions: Within the confines of these experimental parameters it was not possible to 
generate identifiable muscle using the clonal populations. When reviewing the previously 
successful reports of myogenic conversion, cells utilised have either been derived from 
tissues that are already ‘primed’ with the requisite myogenic genetic potential or have 
undergone specific genetic reprogramming to enhance the myogenic conversion rate. This, 
along with as yet unidentified stromal interplay, may therefore be required for positive 
myogenic differentiation to be realised.  
*Manuscript text
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Introduction 
Oral mucosal lamina propria progenitor cells (OMLP-PCs) are a distinct progenitor cell (PC) 
population that has recently been reported [1]. These oral PCs are of neural crest origin, 
express many putative stem cell markers and are potently immunosuppressive [2]. 
Furthermore, these OMLP-PCs, like bone marrow-derived mesenchymal stem cells (BM-
MSCs), adipose-derived stem cells (ADSCs) and gingiva-derived progenitor cells can be 
driven down osteoblastic, adipogenic, chondrogenic and neuronal lineages [1,3,4,5]. 
 
Myogenesis is characterized by a period of myoblast proliferation, followed by the 
expression of muscle-specific proteins and then fusion to form multinucleated myotubes. It is 
a developmental cascade that principally involves the regulatory MYOD gene family 
controlling the transition of multipotential mesodermal stem/PCs into the myogenic lineage 
[6]. 
 
Both human and animal studies have sought to reproduce the muscle phenotype from 
embryologically distinct tissue types. Early studies by Guan et al., (1999) [7] developed 
protocols for cultivating embryonic stem cells (ESCs) through ‘hanging drop/embryoid body’ 
stages prior to their differentiation to skeletal muscle. Later animal studies by Zheng et al., 
(2006) [8] demonstrated that human ESC-derived precursors could incorporate into host 
muscle efficiently and become part of regenerating muscle fibres. Adult MSCs, most 
commonly BM-MSCs, have been reported to form skeletal muscle under defined in vitro 
conditions [9,10]. In vivo studies have demonstrated that BM-MSCs differentiate into 
myofibres and contribute to the replenishment of the muscle satellite cell compartment and 
thus to muscle regeneration [11]. 
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Recent work has reported successful derivation of myogenic cell-types with in vitro 
manipulation of cells from a variety of tissue sources. Gang and co-workers (2004) [12] 
demonstrated that umbilical cord blood-derived MSCs, when incubated in pro-myogenic 
conditions expressed myogenic markers in accordance with the myogenic differentiation 
pattern. Murine ADSCs were reported to convert to the myogenic phenotype when in co-
culture with primary myoblasts [13] and enhanced conversion rates were realised when 
utilising stiffened ‘muscle-mimicking’ extracellular matrices that more closely imitate the in 
vivo situation [14].  
 
Further investigations have utilised more invasive methods of cellular and genetic 
manipulation in order to achieve differentiation. Work by Taylor and Jones (1979) [15] 
(replicated by Wakitani et al., 1995 [16]), on use of the DNA methylation inhibitor 5-
azacitidine (5-Aza), reported that subpopulations of mouse and rat cell lines undergo 
transformation to the myotube muscle phenotype when treated. Nakatsuka et al. (2010) [17] 
demonstrated 5-Aza demethylation resulted in skeletal muscle differentiation by mouse 
dental pulp stem cells. Authors have also demonstrated similar in vitro muscle conversion on 
utilisation of the ß-galactoside-binding lectin Galectin-1. Goldring et al. (2002) [18] reported 
that human dermal fibroblasts expressed the myogenic marker, Desmin, and Chan et al., 
(2006) [19] presented data that suggest human foetal-MSCs readily undergo muscle 
differentiation in response to Galectin-1. The purpose of this study was specifically not to 
undertake such invasive molecular manipulation techniques but rather to investigate any 
innate myogenic potential in order to be able to exploit this via pre-published myogenic 
maintenance/differentiation tissue culture protocols which may lend themselves towards 
future translatability. 
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In addition, there are reports that suggest conversion rates for functioning muscle may be 
exaggerated. Di Castro et al. (2008) [20] cited conflicting evidence of myogenic 
differentiation from human haematopoietic-derived stem cells. They demonstrated that 
human peripheral blood-derived stem cells labelled with Green Fluorescent Protein (GFP) 
and co-cultured with mouse C2C12 myoblast cell line demonstrated transference of GFP 
markers to muscle cells but without the signs of myogenic stem cell differentiation. It appears 
that the method of stem cell and muscle fibre fusion is not clear and it is debated as to 
whether this represents true cellular fusion, transdifferentiation or the effects of circulating 
tissue-specific precursors.  
 
Given the multipotent nature of OMLP-PCs and the ease with which these can be isolated 
from individuals (via a simple non-scarring buccal mucosal biopsy) the aim of this 
investigation was to determine their potential to form identifiable muscle subunits when 
subjected to previously published myogenic tissue culture approaches.   
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Materials and Methods  
Isolation and expansion of the OMLP-PCs 
Unless otherwise stated all laboratory reagents were obtained from Invitrogen, UK. Normal, 
disease-free buccal mucosa biopsies were obtained from written consented patients 
undergoing dental procedures at the School of Dentistry, Cardiff University. Local ethical 
committee approval had been previously obtained (South East Wales Research Ethics 
Committee; 09/WSE03/18). OMLP PCs were obtained by differential adhesion to fibronectin 
as previously reported [1]. In brief, biopsy tissue was separated into epithelial and lamina 
propria component. LP tissue was then disaggregated and PCs were separated by subsequent 
differential adhesion to fibronectin. Briefly, OMLP single-cell suspensions in basal culture 
media (Dulbecco’s modified Eagle’s medium [DMEM] supplemented with 2 mM l-
glutamine, 100 U/mL penicillin G, 100 μg/mL streptomycin sulfate, 0.25 μg/mL 
amphotericin B) were seeded onto fibronectin (10 μg/mL overnight pre-coating; Sigma-
Aldrich Company Ltd) coated 6-well plates and incubated for 20 min at 37°C. Non-adherent 
cells within this time frame were discarded and adhered cells were allowed to form single-
cell colonies. A total of nine clones were isolated and expanded from n=3 patients (i.e. 3 
clones per patient) and cells utilized in experiments at 22-35 population doublings. Previous 
work has concluded that PC populations passaged through basal medium were characterized 
by a high initial rate of proliferation (on average >4 PDs/week), before establishing a 
constant level of 1 PD/week and reaching cellular senescence at ~50–60 PDs. These growth 
kinetics were representative of all clones utilised in these investigations. 
 
The control culture utilised was the murine myoblast muscle cell line C2C12, originally 
obtained by Yaffe and Saxel (1977) [21] through serial passage of myoblasts cultured from 
the thigh muscle of C3H mice after crush injury. 
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Myogenic Cell Culture Variables 
Media composition 
In an attempt to drive myogenic conversion of our PCs they were subjected to media 
conditions previously published as being successful in driving the muscle phenotype in 
committed muscle cell culture [22,23,24,25]. Media formulations were based on DMEM 
basal media (as above) with the addition of varying horse serum combinations and the 
inclusion of insulin-like growth factor-1 (10 ng/ml) and the corticosteroids dexamethasone 
(0.1 µM) and hydrocortisone (50 µM). Specifically, PCs were subject to an initial high (10%) 
horse serum concentration to induce differentiation (Differentiating Medium [DM]), levels 
were then reduced to 2% in order to stimulate cellular fusion (Fusion Medium [FM]) (media 
formulations described by Gang et al., 2004) [12].  
 
Gene modifying reagents 
A further methodology involved the use of the demethylation gene-modifying reagent 5-Aza 
(Sigma, A3656) and the lectin Galectin-1 (Sigma, G4720). Clones were seeded and cultured 
in in T75 flasks and standard DMEM/foetal calf serum growth medium at 37°C until 
established and the then media changed to DM containing 0.3 µM 5-Aza for 3 days, or 200 
ng/ml Galectin-1 for 14 days (media being replenished every three days). After these time 
periods medium was changed to fresh DM for two further days then to FM for four weeks. 
 
Culture substrate conditioning 
This technique involved the mechanical conditioning of tissue culture substrates utilising 
either (a) gelatin, (b) rat tail type I collagen (Life Technologies, A1048301), (c) Matrigel™ 
(BD Biosciences; Grefte et al., (2012) [26]) or (d) tuneable polyacrylamide gels (Engler et 
al., (2004) [27]). Briefly, 0.2% w/v gelatin or 0.2 mg/ml type I collagen were adhered to 
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tissue culture plastic overnight at 37°C. Matrigel™ at 1 mg/ml was used to coat 24-well 
plates at 37°C overnight.  
 
3D Cell Culture 
Based on work conducted by Smith et al., (2012) [28] an in vitro 3-dimensional construct 
was used to support tissues during the differentiation protocols. Wire supports were 
constructed to hold in position a 2 mm pore size nylon mesh suspended between the walls of 
a single well (9.4 cm2) chamber slide (Lab-Tek®, UK). Cells were suspended in 3 ml of 
neutralised type I collagen (0.1% w/v). The cell/collagen matrix was then lifted to release it 
from the floor of the chamber and DM was replaced daily throughout 7 days of culture. 
 
Culture substrate conditioning 
Solutions of acrylamide (6% w/v) and bis-acrylamide (0.14% w/v) were polymerized by 
ammonium persulfate (1:100 v/v) and tetramethylethylenediamine (1:1000 v/v). These 
hydrogels were then cast between a glass coverslip activated with 3-
aminopropyltrimethoxysilane and a glass slide activated with dichlorodimethylsiloxane. The 
hydrogel surface layer was then activated with application of sulfo-SANPAH solution and 
exposure to 365 nm UV light. Fresh type I collagen solution (0.2 mg/ml) was utilised to cover 
the gel surface at 37°C overnight. The coated coverslips were UV sterilised before being 
utilised in cell culture experiments. 
 
RT-PCR 
Total RNA was purified with Trizol® reagent and treated with DNA-Free DNase I treatment 
(Ambion, Austin Texas, USA) to remove genomic DNA contamination. Two micrograms of 
total RNA was used for the reverse-transcription reaction with random hexamer primers 
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(Promega, UK). PCR was performed utilising the Invitrogen supermix and products 
visualised on a 10% agarose gel. Published primers were for β-actin [F 5’-CCA CAC TGT 
GCC CAT CTA CGA GGG GT-3’ and R 5’ AGG GCA GTG ATC TCC TTC TGC ATC CT 
[1] and MyoD1 [F 5’ AAG CGA CCT CTC TTG AGG TA 3’ and R 5’ GCG CCT TTA TTT 
TGA TCA CC 3’ [25]. A Desmin primer [F 5’ GAC CAC GCG CAC CAA CGA GA 3’ and 
R 5’ CCG CTC GGA AGG CAG CCA AA 3’]) was designed using Blast primer design 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). cDNAs created from Total Human 
Skeletal Muscle (Agilent, Stratagene Products, UK) and C2C12 myoblast cell line RNs were 
used as positive controls. 
 
Immunostaining 
Cells were fixed with 4% (w/v) paraformaldehyde for 10 mins and washed in tris-buffered 
saline three times. Samples were blocked with rabbit serum at 1:50 for 30 mins and then 
incubated with primary Desmin antibody (Dako, UK; 0.02 mg/ml) for 1 hour at room 
temperature with agitation. After washing, secondary FITC-conjugated rabbit anti-mouse 
(Dako, UK; 1 µg/ml) in 2% non-fat milk was added and incubated for 1 hour. Nuclei were 
counter-stained with 1 μg/ml Hoechst33342 (Invitrogen, Carlsbad, CA, USA) and slides 
mounted in Crystalmount™ before imaging by epi-fluorescent microscopy.  
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Results 
Myogenic Lineage potential of OMLP-PCs: Previous work by our group [1] has demonstrated 
that all OMLP-PC clones derived express the stem cell marker series CD44, CD90, CD105, 
CD166 and were negative for the hematopoietic and fibrocyte markers CD34 and CD45. 
These studies have also demonstrated the multipotency of OMLP-PCs by differentiation of 
the cells down mesenchymal (chondrogenic, osteoblastic, and adipogenic) and neuronal cell 
lineages (1). To characterise the baseline myogenic lineage potential, initial assessment of the 
cells maintained either within myogenic culture media alone or in conjunction with 5-Aza 
was undertaken. End-point RT-PCR analysis revealed the expanded OMLP-PCs to be 
negative for both Desmin and MyoD1 when untreated and after attempted myogenic 
conversion (Fig. 1 & Table 1). The C2C12 control was positive for both markers. 
 
The effect of defined ‘myogenic’ media on OMLP-PC myo-differentiation: In culture there 
were no discernible morphological changes between non-treated cultures and those subjected 
to myogenic media formulations (Figs. 2A&B). Clonal OMLP-PC populations failed to 
demonstrate positive immuno-staining for Desmin even after exposure to the different 
myogenic cell culture protocols (Figs. 2C&D). This was in distinct contrast to the C2C12 cell 
line that continued to undergo growth, proliferation and eventual fusion to the myotube 
phenotype which demonstrated Desmin positivity (Figs. 2E-H). 
 
DNA manipulation and myogenic conversion: OMLP-PCs were individually exposed to 5-
Aza and Galectin-1. After treatment with 5-Aza there was evidence of the cells becoming 
larger, more flattened and forming numerous filopodia however, this was not characteristic of 
myotube formation (Fig. 3A). After exposure to Galectin-1 there were no discernible 
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morphological changes to the cells in culture (Fig. 3B). There continued to be a lack of 
Desmin antibody staining following treatment with both reagents (data not shown). 
 
The effect of culture substrate on OMLP-PC myo-differentiation: Although all substrates 
were permissive for normal OMLP-PC growth (Fig. 4A), myogenic differentiation was once 
again only observed for the control C2C12 cells and not for the OMLP-PCs (Fig. 4B). 
 
The effect of substrate stiffness on OMLP-PC myo-differentiation: A growing body of work 
has demonstrated that in vitro culture substrate stiffness can influence the direction of 
differentiation of ‘progenitor’ cells. Engler and co-workers (2004) [27] have previously 
demonstrated that a specific Young’s modulus (E) of ≈10KPa can result in myogenic 
differentiation of human MSCs. Following this methodology we produced tuneable 
polyacrylamide gels that were tested for stiffness using rheology. Three gel thicknesses (0.4, 
0.6 and 1.0 mm) were developed with a range of stiffness from 8.8 to 9.2 KPa. OMLP-PCs 
when cultured on these polyacrylamide ‘stiff’ substrates responded to the morphological cues 
by flattening out, forming numerous processes and elongating (Figs. 5A-D). However, this 
change of appearance was not indicative of a myotube-like phenotype when compared to the 
response of the C2C12 control cell line. This was further confirmed through staining for 
Desmin in the C2C12 controls whilst there was no Desmin positivity in the OMLP-PCs (Figs. 
5E-F). 
 
The effect of 3-dimensional culture on OMLP-PC myo-differentiation: Reorganisation of a 
3D extracellular matrix environment was demonstrated for the OMLP-PCs but 
macroscopically this was substantially less than for the control C2C12 cells which resulted in 
detachment of the collagen lattice from the surrounding support structures (Figs. 6A&B). 
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Microscopic examination of the cell-seeded lattices revealed distinct differences between 
OMLP-PC and C2C12 systems in that, unlike the C2C12 cells the oral progenitor cells did 
not take on the appearance of myotubes or stain positively for Desmin (Figs. 6C-F). 
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Discussion 
The innate ability of embryologically distinct tissue types to differentiate to muscle has been 
attributed to a small percentage of pre-existing cells that already express myogenic genes 
such as Myf5, MYOD, Myogenin and Desmin [29]. However, all such reports to date have 
resulted in disappointingly small numbers of muscle differentiating cells. This may suggest 
that tissue ‘stem’/‘progenitor’ cells are in a dynamic state, constantly changing in response to 
the microenvironment/stromal cell counterparts/cell density and can maintain their myogenic 
phenotype only under the effect of numerous specific cues. Replication of these conditions in 
in vitro culture is unfortunately, far from completely understood. 
 
It was clear for the described investigations that OMLP-PC clones could not take on a 
myogenic phenotype. This inability to demonstrate myotube-like structures and the 
expression of Desmin in OMLP clonal populations, despite the use of multiple published 
myogenic culture protocols, indicates that modified cell culture environments alone are not 
able to drive these expanded clonal oral progenitors down a myogenic pathway. As with all in 
vitro investigations some consideration must be given to the fact that the clones had to be 
culture expanded and therefore there may be some potential alteration of their phenotype 
from that of a native, tissue-resident OMLP-PC. It is also possible of course that mixed (non-
clonal) populations of OMLP-PCs could harbour sub-populations from the neural crest-
derived lamina propria that may actually be needed to drive progenitor cell myogenic 
differentiation. 
 
Published work has demonstrated that the DNA methylating agent 5-Aza can induce 
differentiation of PCs down a myogenic lineage as evidenced by the production of myotubes 
from mouse and rat BM-MSCs [15,16] and mouse dental pulp stem cells [17]. However, as 5-
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Aza is a highly potent DNA methylating agent and therefore alters the epigenetic control of 
gene expression, it is unknown whether these cells are indeed pluripotent or whether 
pluripotency/skeletal muscle differentiation is being induced via methylation alone. Such 
alteration in gene expression was not intrinsic to this particular study however, it was 
demonstrated that 5-Aza could not drive the myogenic differentiation of the tested OMLP-
PCs. This result differed to studies by Gornostaeva et al., (2006) [30] where myogenesis was 
observed in prenatal-MSCs derived from the main sites of haemopoiesis (bone marrow, 
thymus, liver). Interesting however, this study failed to identify myogenic conversion when 
using splenic MSCs. This suggests a difference in differentiation potential of MSCs from 
haemopoietic organs dependent upon the source of cells. Interestingly, Nakatsuka et al., 
(2010) [17] utilised dental pulp stem cells in their myogenic differentiation investigations. 
Exposure to 5-Aza drove myotube formation significantly however, this first required 
transfection with the MYOD1 gene and (in line with the findings with OMLP-PCs) no 
myotube-like structures were observed in the control dental pulp cells despite use of 
myogenic medium. 
 
Experimentation by Engler et al. (2004) [27] has demonstrated myogenic conversion of 
human MSCs when cultured upon polyacrylamide gel substrates of known stiffness. They 
report that the physical nature of a cell’s microenvironment, specifically the elasticity of the 
surrounding tissues, exerted influence upon morphology, cytoskeleton and gene expression. 
In vitro work had demonstrated that committed muscle cells developed skeletal muscle 
sarcomeric striations only when the cells were grown on a compliant gel that closely matched 
the passive compliance of skeletal muscle. Later work revealed that, with the same gels, 
MSCs maximally express myogenic genes, even in the absence of tailored soluble factors. 
Our replication of such systems certainly produced alterations in cellular morphology and 
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indeed there were variations in both C2C12 and progenitor cell turnover and appearance 
however, true multinucleate cells were not identified in the OMLP-PC clones which also did 
not stain positively for Desmin. 
 
To promote the greatest levels of cellular maturation and functionality in an in vitro culture it 
is generally accepted that a 3D extracellular matrix is required which more accurately models 
in vivo situation [31]. Utilising a 3D protocol devised by Smith et al., (2012) [28] when type I 
collagen gel systems were seeded with either C2C12 or the OMLP-PCs both cell sources 
were able to reorganise the matrix and undergo replication within their respective 3D 
environments. Some contraction of the matrix by the OMLP-PCs was expected due to passive 
remodelling of the matrix but this was noticeably less when compared to the control muscle 
cell line. This differential result correlated with a lack of acquisition of a morphological or 
immunohistochemically-identified myogenic phenotype in the OMLP-PC cohort. 
 
In summary, neural crest derived OMLP-PC clones do not intrinsically express markers of 
the myogenic lineage. Despite experimentation with several (published) in vitro myogenic 
culture protocols that have included specific culture media components and culture substrate 
conditioning we were unable to drive the OMLP-PCs down a myogenic lineage. Nor were the 
OMLP-PC populations able to be driven into a muscle phenotype when stimulated by a 3D 
collagenous environment. In support of our findings, current data in the field of deriving 
muscle from progenitor cells which have a potential to ‘convert’ to a myogenic lineage is still 
limited. Indeed, the majority of successful in vitro muscle studies have utilised cells derived 
from tissues that are already ‘primed’ with the requisite myogenic genetic potential to 
convert. Significant gaps in our knowledge still exist with respect to the muscle 
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microenvironment and the cell-cell, cell-stromal interactions required to convert to and 
maintain an in vitro muscle cell system.  
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Figure Captions 
Fig. 1: Myogenic Polymerase Chain Reaction 
RT-PCR analysis demonstrating positive identification of myogenic markers Desmin and 
MYOD1 within positive control C2C12 muscle cell line but a lack of expression in the 
OMLP-PC clones. 
 
Fig. 2: Comparisons of OMLP clones and control under myogenic media conditions 
Unchanged morphology of OMLP clones (a) before and (b) after culture under myogenic 
media conditions. OMLP-PC failure to demonstrate positive Desmin immuno-staining both 
(c) before and (d) after exposure to myogenic culture. C2C12 cells (e) before and (f) after 
culture under myogenic media conditions demonstrating multinucleate myotube formation. 
C2C12 cells demonstrating positivity for Desmin both (g) before and (h) after culture under 
myogenic media conditions. 
 
Fig. 3: OMLP-PCs after DNA manipulation culture conditions 
OMLP at 3 days exposure to (a) 5-Aza with evidence of the cells becoming larger, more 
flattened and forming numerous filopodia and (b) Galectin-1. Neither condition resulted in 
myotube formation. 
 
Fig. 4a: Collagen tissue culture substrates 
(a) OMLP-PCs cultured upon type I collagen; (i) cell morphology and (ii) negative Desmin 
staining. OMLP-PC cell morphology after culture upon type I collagen and with the addition 
of 5-Aza (iii) and subsequent negative Desmin staining (iv). C2C12 cells cultured upon type I 
collagen; (v) cell morphology and (vi) positive Desmin IHC staining. C2C12 cell 
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morphology after culture upon type I collagen and with the addition of 5-Aza (vii) and 
subsequent positive Desmin staining (viii). 
 
Fig. 4b: Matrigel tissue culture substrates 
(b) OMLP-PCs cultured upon Matrigel; (i) cell morphology and (ii) negative Desmin 
staining. OMLP-PC morphology after culture upon Matrigel and with the addition of 5-Aza 
(iii) and subsequent negative Desmin staining (iv). C2C12 cells cultured upon Matrigel; (v) 
cell morphology and (vi) positive Desmin IHC staining. C2C12 cell morphology after culture 
upon Matrigel and with the addition of 5-Aza (vii) and subsequent positive Desmin staining 
(viii). 
 
Fig. 5: The effect of substrate stiffness on OMLP-PC myo-differentiation 
(a) OMLP-PCs and (b) C2C12 cells cultured upon polyacrylamide substrates in the presence 
of myogenic medium. (c) OMLP-PCs and (d) C2C12 cells cultured upon polyacrylamide 
substrates in the presence of myogenic medium and the addition of 5-Aza. (e) OMLP-PCs 
cultured upon polyacrylamide substrates demonstrating a lack of Desmin staining. (f) C2C12 
cells cultured upon polyacrylamide substrates demonstrating Desmin positivity. 
 
Fig. 6: The effect of 3-dimensional culture on OMLP-PC myo-differentiation 
(a) Reorganisation of the 3D extracellular matrix environment by the OMLP-PCs. (b) 
Reorganisation of the 3D extracellular matrix environment by C2C12 cells demonstrating 
increased contraction (and subsequent detachment) compared to the OMLP-PCs. The 
appearance of the (c) OMLP-PCs and (d) C2C12 cells within the 3D collagen lattices. (e) 
Negative Desmin staining of OMLP-PCs within 3D collagen lattice as opposed to (f) positive 
Desmin staining of the C2C12 cells.  
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Table 1: Myogenic polymerase chain reaction results 
Undifferentiated OMLP-PCs did not express myogenic markers nor could they be stimulated 
to do so by alteration of the culture conditions. The positive control C2C12 muscle cell line 
demonstrated expression of myogenic markers 
  OMLP-PC Clones (combined cell data) 
PCR Product Untreated Cells 
Myogenic 
Media 
Exposure 
5-Aza 
Exposure 
+ve 
Control 
-ve 
Control 
Muscle 
Desmin 
(335bp) - - - 
+ C2C12 
myoblast 
RNA 
- H2O 
MyoD1 
(515bp) - - - 
+ C2C12 
myoblast 
RNA 
- H2O 
Control Actin (480bp) + + + 
+ total 
Human 
Skeletal 
Muscle 
RNA 
- H2O 
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No Primer 
RT control 
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Desmin 
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Β-actin 
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